Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael K K Li

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|January 30, 2014
Ketamine-induced cholangiopathyK L Lui, W K Lee, Michael K K Li
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 8, 2011
Gastric melanomaS T Law, Michael K K Li, W H Lo
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 10, 2014
A rare cause of haematochezia: pyogenic granuloma in colonK L Lui, K S Ng, Michael K K Li
Journal of Viral Hepatitis|September 7, 2018
Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir - A prospective studyHenry L Y Chan, Fiona W S Chan, Aric J Hui, et al.
Clinical and Molecular Hepatology|August 29, 2020
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairmentDesmond Y H Yap, Kevin S H Liu, Yu-Chun Hsu, et al.
Inflammatory Bowel Diseases|March 5, 2015
Factors associated with mucosal healing in patients with ulcerative colitis in clinical remissionHai Yun Shi, Francis K L Chan, Steven W C Tsang, et al.
Journal of Gastroenterology and Hepatology|May 25, 2010
Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1Owen T-Y Tsang, Jonpaul S-T Zee, Jacky M-C Chan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 5, 2013
Use of biologics for inflammatory bowel disease in Hong Kong: consensus statementW K Leung, Siew C Ng, Dorothy K L Chow, et al.
Journal of Gastroenterology and Hepatology|May 6, 2017
Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosisLung-Yi Mak, Siew C Ng, Irene O L Wong, et al.
Alimentary Pharmacology & Therapeutics|October 23, 2019
Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's diseaseJoyce Wing Yan Mak, Whitney Tang, Terry Cheuk Fung Yip, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|January 30, 2014
Ketamine-induced cholangiopathyK L Lui, W K Lee, Michael K K Li
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 8, 2011
Gastric melanomaS T Law, Michael K K Li, W H Lo
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 10, 2014
A rare cause of haematochezia: pyogenic granuloma in colonK L Lui, K S Ng, Michael K K Li
Journal of Viral Hepatitis|September 7, 2018
Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir - A prospective studyHenry L Y Chan, Fiona W S Chan, Aric J Hui, et al.
Clinical and Molecular Hepatology|August 29, 2020
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairmentDesmond Y H Yap, Kevin S H Liu, Yu-Chun Hsu, et al.
Inflammatory Bowel Diseases|March 5, 2015
Factors associated with mucosal healing in patients with ulcerative colitis in clinical remissionHai Yun Shi, Francis K L Chan, Steven W C Tsang, et al.
Journal of Gastroenterology and Hepatology|May 25, 2010
Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1Owen T-Y Tsang, Jonpaul S-T Zee, Jacky M-C Chan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 5, 2013
Use of biologics for inflammatory bowel disease in Hong Kong: consensus statementW K Leung, Siew C Ng, Dorothy K L Chow, et al.
Journal of Gastroenterology and Hepatology|May 6, 2017
Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosisLung-Yi Mak, Siew C Ng, Irene O L Wong, et al.
Alimentary Pharmacology & Therapeutics|October 23, 2019
Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's diseaseJoyce Wing Yan Mak, Whitney Tang, Terry Cheuk Fung Yip, et al.
Pageof 2